LRP1B and hepatocellular carcinoma: Nevertheless, other studies have shown that the LRP1B mutations are associated with a worse prognosis in hepatocellular carcinoma (HCC) patients and with a poor response to ICI, being also related to TMB and immune infiltration [21,26].